Paper39296266
A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.
Froney MM and 12 others. ACS Pharmacol Transl Sci, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway. Papers, record 39296266. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39296266
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016086 | NCI NIH HHS | United States | P30CA016086 | PubMed and NIH | NIH RePORTER |
| R03 CA252796 | NCI NIH HHS | United States | R03CA252796 | PubMed and NIH | NIH RePORTER |
References104
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27595911 | The C-Circle Assay for alternative-lengthening-of-telomeres activity. | Methods | 2017 | https://conductscience.org/library/papers/27595911 | PubMed |
| 2 | 22416102 | Association of age at diagnosis and genetic mutations in patients with neuroblastoma. | JAMA | 2012 | https://conductscience.org/library/papers/22416102 | PubMed |
| 3 | 10811633 | Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10811633 | PubMed |
| 4 | 27323951 | Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. | Genome Med | 2016 | https://conductscience.org/library/papers/27323951 | PubMed |
| 5 | 22246237 | Increased PARP-1 association with DNA in alkylation damaged, PARP-inhibited mouse fibroblasts. | Mol Cancer Res | 2012 | https://conductscience.org/library/papers/22246237 | PubMed |
| 6 | 10838414 | A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. | J Biomol Screen | 1999 | https://conductscience.org/library/papers/10838414 | PubMed |
| 7 | 19684619 | A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. | Oncogene | 2009 | https://conductscience.org/library/papers/19684619 | PubMed |
| 8 | 32060267 | MYCN amplification and ATRX mutations are incompatible in neuroblastoma. | Nat Commun | 2020 | https://conductscience.org/library/papers/32060267 | PubMed |
| 9 | 26578802 | SMARCAL1 maintains telomere integrity during DNA replication. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26578802 | PubMed |
| 10 | 4373242 | Proteinase K from Tritirachium album Limber. | Eur J Biochem | 1974 | https://conductscience.org/library/papers/4373242 | PubMed |
| 11 | 34840249 | Liquid biopsies in pediatric oncology: opportunities and obstacles. | Curr Opin Pediatr | 2022 | https://conductscience.org/library/papers/34840249 | PubMed |
| 12 | 21889194 | BET bromodomain inhibition as a therapeutic strategy to target c-Myc. | Cell | 2011 | https://conductscience.org/library/papers/21889194 | PubMed |
| 13 | 36265486 | TERRA and RAD51AP1 promote alternative lengthening of telomeres through an R- to D-loop switch. | Mol Cell | 2022 | https://conductscience.org/library/papers/36265486 | PubMed |
| 14 | 37540673 | Two opposing gene expression patterns within ATRX aberrant neuroblastoma. | PLoS One | 2023 | https://conductscience.org/library/papers/37540673 | PubMed |
| 15 | 23881923 | BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23881923 | PubMed |
| 16 | 24466405 | The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface. | Medchemcomm | 2013 | https://conductscience.org/library/papers/24466405 | PubMed |
| 17 | 19873981 | Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. | J Med Chem | 2009 | https://conductscience.org/library/papers/19873981 | PubMed |
| 18 | 23118055 | Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Cancer Res | 2012 | https://conductscience.org/library/papers/23118055 | PubMed |
| 19 | 22740357 | Principles for high-quality, high-value testing. | Evid Based Med | 2013 | https://conductscience.org/library/papers/22740357 | PubMed |
| 20 | 31086012 | Histone H3 Mutations: An Updated View of Their Role in Chromatin Deregulation and Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31086012 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40586839 | Telomerase targeting as a therapeutic approach for sensitizing cancer cells to radiotherapy. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40586839 | PubMed |
| 39729394 | Identification of modulators of the ALT pathway through a native FISH-based optical screen. | Cell Rep | 2025 | https://conductscience.org/library/papers/39729394 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39296266
GET https://conductscience.org/api/papers/v1/39296266/references?page=2